November 27th 2024
As biopharma anticipates the “Facility of the Future,” a definition of what closed processing is, and quantification of its value, can be helpful information.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Sartorius Stedim's New Testing Services to Focus on mAbs and biosimilars
May 5th 2017Operated by BioOutsource, Sartorius’ subsidiary, the Glasgow, UK-based service center will offer physicochemical properties and structural attributes testing and allow clients to perform structural and functional analyses in parallel.
Avid Bioservices Adds Single-Use Bioreactors to Expand Manufacturing in California
May 1st 2017Avid, a wholly owned subsidiary of Peregrine Pharmaceuticals, will upgrade its Myford, California clinical and commercial manufacturing facility with multiple Mobius 2000-L single-use bioreactors from MilliporeSigma, the companies announced on May 1, 2017.